These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 30688105)

  • 41. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.
    Kouton L; Boucraut J; Devaux J; Rajabally YA; Adams D; Antoine JC; Bourdain F; Brodovitch A; Camdessanché JP; Cauquil C; Ciron J; Dubard T; Echaniz-Laguna A; Grapperon AM; Juntas-Morales R; Kremer L; Kuntzer T; Labeyrie C; Lanfranco L; Léger JM; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Merle P; Noury JB; Rouaud V; Tard C; Théaudin M; Vallat JM; Viala K; Attarian S; Delmont E
    Clin Neurophysiol; 2020 Apr; 131(4):921-927. PubMed ID: 32078921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
    Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
    Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duration of the distal compound muscle action potential for diagnosis of chronic inflammatory demyelinating polyneuropathy: effects of low-cut filters.
    Isose S; Misawa S; Sonoo M; Shimuzu T; Oishi C; Shibuya K; Nasu S; Sekiguchi Y; Mitsuma S; Beppu M; Omori S; Komori T; Kokubun N; Inaba A; Hirashima F; Kuwabara S;
    J Clin Neurophysiol; 2014 Oct; 31(5):441-3. PubMed ID: 25271683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathy.
    Tankisi H; Otto M; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
    Clin Neurophysiol; 2012 Oct; 123(10):2099-105. PubMed ID: 22560637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy.
    Broers MC; Bunschoten C; Drenthen J; Beck TAO; Brusse E; Lingsma HF; Allen JA; Lewis RA; van Doorn PA; Jacobs BC
    Eur J Neurol; 2021 Jun; 28(6):2065-2073. PubMed ID: 33657260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy.
    Thaisetthawatkul P; Logigian EL; Herrmann DN
    Neurology; 2002 Nov; 59(10):1526-32. PubMed ID: 12451191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study.
    Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sakurai T; Shimohata T; Katsuno M; Sobue G
    J Neurol Sci; 2018 Nov; 394():99-106. PubMed ID: 30243104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrodiagnostic errors contribute to chronic inflammatory demyelinating polyneuropathy misdiagnosis.
    Allen JA; Ney J; Lewis RA
    Muscle Nerve; 2018 Apr; 57(4):542-549. PubMed ID: 29053880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiological entrapment syndromes in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Muscle Nerve; 2011 Sep; 44(3):444-7. PubMed ID: 21996806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Two elderly cases of transthyretin amyloid polyneuropathy without a family history].
    Nomura T; Oshima Y; Yoshino M; Matsushima M; Yabe I; Sasaki H
    Rinsho Shinkeigaku; 2020 Oct; 60(10):688-692. PubMed ID: 32893242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy.
    Clouston PD; Kiers L; Zuniga G; Cros D
    Electroencephalogr Clin Neurophysiol; 1994 Aug; 93(4):245-54. PubMed ID: 7521284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?
    Capasso M; Torrieri F; Di Muzio A; De Angelis MV; Lugaresi A; Uncini A
    Clin Neurophysiol; 2002 Mar; 113(3):346-53. PubMed ID: 11897535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrodiagnostic data-driven clustering identifies a prognostically different subgroup of patients with chronic inflammatory demyelinating polyneuropathy.
    Baek SH; Hong YH; Choi SJ; Ahn SH; Park KH; Shin JY; Sung JJ
    J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):674-680. PubMed ID: 30904899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
    Lagarde J; Viala K; Fournier E
    Muscle Nerve; 2014 Jun; 49(6):895-9. PubMed ID: 24114712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal Dispersion and Duration of the Distal Compound Muscle Action Potential Do Not Distinguish Diabetic Sensorimotor Polyneuropathy From Chronic Inflammatory Demyelinating Polyneuropathy.
    Alcantara M; Ngo M; de la Cruz J; Menon D; Barnett-Tapia C; Katzberg H; Bril V
    Front Neurol; 2022; 13():872762. PubMed ID: 35557614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Magy L; Diallo L; Boukhris S; Vallat JM
    Muscle Nerve; 2012 Jan; 45(1):26-31. PubMed ID: 22190302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study.
    Du K; Li F; Wang H; Miao Y; Lv H; Zhang W; Wang Z; Yuan Y; Meng L
    Ann Clin Transl Neurol; 2021 Apr; 8(4):831-841. PubMed ID: 33739616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants.
    De Lorenzo A; Liberatore G; Doneddu PE; Manganelli F; Cocito D; Briani C; Fazio R; Mazzeo A; Schenone A; Di Stefano V; Cosentino G; Marfia GA; Benedetti L; Carpo M; Filosto M; Antonini G; Clerici AM; Luigetti M; Matà S; Rosso T; Lucchetta M; Siciliano G; Lauria Pinter G; Cavaletti G; Inghilleri M; Cantisani T; Notturno F; Ricciardi D; Habetswallner F; Spina E; Peci E; Salvalaggio A; Falzone Y; Strano C; Gentile L; Vegezzi E; Mataluni G; Cotti Piccinelli S; Leonardi L; Romano A; Nobile-Orazio E;
    Eur J Neurol; 2024 Apr; 31(4):e16190. PubMed ID: 38165011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.